期刊文献+

洛索洛芬钠混合性缓释片的制备 被引量:1

Preparation of the Mixed Matrix Tablets of Loxoprofen Sodium
下载PDF
导出
摘要 目的:制备洛索洛芬钠混合性缓释片并考察其体外释放度。方法:采用混合骨架材料制备洛索洛芬钠混合性缓释片。以硬脂酸为骨架材料,并以药物在222nm的波长处的吸收度为指标考察不同比例的硬脂酸、乙基纤维素、羟丙基甲基纤维素及乳糖对洛索洛芬钠释放速率和影响因素进行考察,确定最优处方。结果:在一定范围内,随着硬脂酸量的减少,乳糖和HPMC含量增加,片剂的累积释放量增加。制备的缓释片可以持续释放药物12小时。结论:制备的洛索洛芬钠混合性缓释片缓释效果良好。 Objective: To prepare the mixed matrix tablets of Loxoprofen sodium and to evaluate their dissolution in vitro. Methods: Mixed matrix materials were used to prepare the tablets. The stearic acid was used to prepare sustained-release tablets by the wet granule compression technique. Ethylcellulose (EC) and hydroxypropyl methylcellulose (HPMC) and lactose were used to adjust the release rate. The content of the major drug was determined by UV spectrophotometry at 222nm, The release mechanism and the influence factors were studied by determining release rates. Results: The cumulative release rates of tablets increased with the decreased proportion of stearic acid and the increased proportion of lactose and HPMC. The tablets could be released continually for 12h. Conclusion: The mixed matrix tablets of Loxoprofen sodium were prepared successfully with perfect performance.
作者 李劲鸿
出处 《现代生物医学进展》 CAS 2008年第1期116-117,共2页 Progress in Modern Biomedicine
关键词 洛索洛芬钠 混合性缓释片 释药速率 Loxoprofen sodium Mixed matrix tablet Release velocity
  • 相关文献

参考文献4

二级参考文献11

  • 1[1]Choo KS, Kim IW, Jung JK, et al. Simultaneous determination of loxoprofen and its diastereomeric alcohol metabolites in human plasma and urine by a simple HPLC-UV detection method. J Pharm Biomed Anal, 2001; 25:639~650.
  • 2[2]Kim IW, Choo KS, Han TG, et al. Decreased oral bioavailability of loxoprofen at second administration in human subjects. Int J Clin Pharmacol Ther, 2000; 38:10~14.
  • 3[3]Hirai T, Matsumoto S, Kishi I. Imultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by highperformance liquid chromatography with normal solid-phase extraction. J Chromatogr B Biomed Sci Appl , 1997; 692:375~388.
  • 4Choo KS, Kim IW,Jung JK, et al. Simultaneous determination of loxoprofen and its diastereomeric alcohol metabolites in human plasma and urine by a simple HPLC- UV detection method[J]. J Pharm Biomed Anal ,2001,25(3 - 4) :639 - 650.
  • 5Kim IW, Choo KS, Han TG, et al. Decreased oral bioavailability of loxoprofen at second administration in htmaan subjects[J]. Int J Clin Pharmacol Ther ,2000,38( 1 ) : 10 - 14.
  • 6Hirai T, Matsumoto S, Kishi I. Simultaneous analyds of several nonsteroidal anti-inflammatory drugs hn human urine by high-performance liquid chromatography with normal solid-phase extraction[J].J Chromatogr B Biomed Sci Appl, 1997,692 (2) : 375 - 388.
  • 7Aritomi H,Ogawa N,Nobunaga T. Efficacy of 156-S against rheumatoid arthritis[J]. Ryumachi, 1986,26 (1): 63-71.
  • 8Sugimoto M, Kojima T, Asami M, et al. Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug [J]. Biochem Pharmacol,1991,42(12) :2363-2368.
  • 9Choo KS,Kim IW,Jung JK,et al. Simultaneous determination of loxoprofen and its diastereomeric alcohol metabolites in human plasma and urine by a simple HPLC-UV detection method [J]. J Pharm Biomed Anal, 2001,25(3-4) :639-650.
  • 10Kim IW, Choo KS, Han TG, et al. Decreased oral bioavailability of loxoprofen at second administration in human subjects[J]. Int J Clin Pharmacol Ther, 2000,38(1 ):10-14.

共引文献17

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部